Literature DB >> 11499739

Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction.

I Sheiban1, G Fragasso, G M Rosano, A Dharmadhikari, V Tzifos, P Pagnotta, S L Chierchia, G Trevi.   

Abstract

OBJECTIVES: We sought to evaluate the importance of time in relation to treatment, time course and determinants of recovery of left ventricular (LV) function in patients with acute myocardial infarction (AMI) undergoing primary percutaneous transluminal coronary angioplasty (PTCA).
BACKGROUND: Myocardial salvage has been shown to be dependent on the time elapsed from the onset of AMI to reperfusion.
METHODS: Left ventricular function was evaluated at hospital admission, after angioplasty, at 24 h and 6 months by both echocardiography and angiography and at 1, 7, 30, 90 and 180 days by echocardiography in 101 consecutive patients.
RESULTS: Patients were allocated to three groups according to interval between symptom onset and angioplasty: <2 h (group A), 2 to 4 h (group B) and >4 h (group C). Patients in groups A and B showed a progressive improvement of LV function between day 7 and day 90, which became statistically significant at day 30 (p < 0.01). No LV function changes were noted in group C patients. Thrombolysis In Myocardial Infarction (TIMI) flow grade <3 at 24 h was not associated with any significant change in LV volume and function during the six-month follow-up period. Restenosis, when associated with TIMI flow grade 3 in the infarct-related vessel, did not influence LV function. Flow grade <3 of the infarct-related artery was not associated with any improvement of cardiac events independently from the time to treatment at the initial procedure.
CONCLUSIONS: Patients undergoing primary PTCA for AMI have a good recovery of LV function if TIMI flow grade 3 is restored within 4 h. Coronary angioplasty limits further remodeling of the LV in patients treated after 4 h.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499739     DOI: 10.1016/s0735-1097(01)01407-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Universal access: but when? Treating the right patient at the right time: access to cardiac rehabilitation.

Authors:  William Dafoe; Heather Arthur; Helen Stokes; Louise Morrin; Louise Beaton
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Delivery and tracking of therapeutic cell preparations for clinical cardiovascular applications.

Authors:  R de Silva; R J Lederman
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414

3.  PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

Authors:  Arshed A Quyyumi; Alejandro Vasquez; Dean J Kereiakes; Marc Klapholz; Gary L Schaer; Ahmed Abdel-Latif; Stephen Frohwein; Timothy D Henry; Richard A Schatz; Nabil Dib; Catalin Toma; Charles J Davidson; Gregory W Barsness; David M Shavelle; Martin Cohen; Joseph Poole; Thomas Moss; Pamela Hyde; Anna Maria Kanakaraj; Vitaly Druker; Amy Chung; Candice Junge; Robert A Preti; Robin L Smith; David J Mazzo; Andrew Pecora; Douglas W Losordo
Journal:  Circ Res       Date:  2016-11-07       Impact factor: 17.367

4.  Prevention of Left Ventricular Remodeling After Myocardial Infarction.

Authors:  Martin St John Sutton; Victor A. Ferrari
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

5.  Left Ventricular Functional Remodeling after Primary Percutaneous Coronary Intervention.

Authors:  Mahesh Kumar Batra; Muhammad Atif Malik; Kamran Ahmed Khan; Lajpat Rai; Rajesh Kumar; Jehangir Ali Shah; Jawaid Akbar Sial; Tahir Saghir; Naveedullah Khan; Musa Karim
Journal:  J Cardiovasc Echogr       Date:  2022-04-20

6.  Sleep Apnea Evolution and Left Ventricular Recovery After Percutaneous Coronary Intervention for Myocardial Infarction.

Authors:  Li-Ling Tan; Jeanette Ting; Iswaree Balakrishnan; Aruni Seneviratna; Lingli Gong; Mark Y Chan; E Shyong Tai; A Mark Richards; Bee-Choo Tai; Lieng-Hsi Ling; Chi-Hang Lee
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

7.  Determinants of left ventricular thrombus formation after primary percutaneous coronary intervention for anterior wall myocardial infarction.

Authors:  LeRoy Elazar Rabbani; Carol Waksmonski; Sohah N Iqbal; Jennifer Stant; Robert Sciacca; Mark Apfelbaum; Osman R Sayan; James Giglio; Shunichi Homma
Journal:  J Thromb Thrombolysis       Date:  2007-06-12       Impact factor: 2.300

Review 8.  The existence of myocardial repair: mechanistic insights and enhancements.

Authors:  Matthew Schoenfeld; William H Frishman; Annarosa Leri; Jan Kajstura; Piero Anversa
Journal:  Cardiol Rev       Date:  2013 May-Jun       Impact factor: 2.644

9.  Predictors of Left Ventricle Remodeling: Combined Plasma B-type Natriuretic Peptide Decreasing Ratio and Peak Creatine Kinase-MB.

Authors:  Jen-Te Hsu; Chang-Min Chung; Chi-Ming Chu; Yu-Shen Lin; Kuo-Li Pan; Jung-Jung Chang; Po-Chang Wang; Shih-Tai Chang; Teng-Yao Yang; Shih-Jung Jang; Tsung-Han Yang; Ju-Feng Hsiao
Journal:  Int J Med Sci       Date:  2017-01-15       Impact factor: 3.738

10.  Five-year follow-up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE-AMI trial.

Authors:  Anthony Mathur; Doo Sun Sim; Fizzah Choudry; Jessry Veerapen; Martina Colicchia; Tymoteusz Turlejski; Mohsin Hussain; Stephen Hamshere; Didier Locca; Roby Rakhit; Tom Crake; Jens Kastrup; Samir Agrawal; Daniel A Jones; John Martin
Journal:  ESC Heart Fail       Date:  2022-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.